Financials data is unavailable for this security.
View more
Year on year BIOLASE Inc had relatively flat revenues (48.46m to 49.16m), though the company grew net income from a loss of 28.63m to a smaller loss of 20.63m. A reduction in the selling, general and administrative costs as a percentage of sales from 70.13% to 58.29% was a component in the net income growth despite flat revenues.
Gross margin | 33.01% |
---|---|
Net profit margin | -41.65% |
Operating margin | -35.84% |
Return on assets | -54.64% |
---|---|
Return on equity | -3,157.50% |
Return on investment | -185.36% |
More ▼
Cash flow in USDView more
In 2023, BIOLASE Inc increased its cash reserves by 57.04%, or 2.39m. Cash Flow from Financing totalled 17.43m or 35.46% of revenues. In addition the company used 14.09m for operations while cash used for investing totalled 1.13m.
Cash flow per share | -1.20 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0636 |
---|---|
Tangible book value per share | -0.1512 |
More ▼
Balance sheet in USDView more
Current ratio | 0.7087 |
---|---|
Quick ratio | 0.3589 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 1.19 |
More ▼